Mankind Pharma Limited (BOM:543904)
India · Delayed Price · Currency is INR 2,469.90
-107.05 (-4.15%)
At close: Jul 31, 2026
Mankind Pharma Market Cap
Mankind Pharma has a market cap or net worth of 1.02 trillion as of July 31, 2026. Its market cap has decreased by -4.05% in one year.
Market Cap
1.02T
Enterprise Value
1.06T
Revenue
147.38B
Ranking
n/a
PE Ratio
49.93
Stock Price
2,469.90
ChartMarket Cap Chart
Since May 9, 2023, Mankind Pharma's market cap has increased from 569.76B to 1.02T, an increase of 79.01%. That is a compound annual growth rate of 19.75%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 1.02T | 12.49% |
| Dec 31, 2025 | 906.73B | -23.70% |
| Dec 31, 2024 | 1.19T | 49.64% |
| Dec 29, 2023 | 794.17B | 39.39% |
| May 9, 2023 | 569.76B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Torrent Pharmaceuticals | 1.94T |
| Lupin | 1.10T |
| Dr. Reddy's Laboratories | 955.93B |
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |